| Product Code: ETC13364057 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Orphan Drug Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Orphan Drug Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Orphan Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Orphan Drug Market - Industry Life Cycle |
3.4 Europe Orphan Drug Market - Porter's Five Forces |
3.5 Europe Orphan Drug Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Orphan Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Europe Orphan Drug Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.8 Europe Orphan Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 Europe Orphan Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Europe Orphan Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Orphan Drug Market Trends |
6 Europe Orphan Drug Market, 2021 - 2031 |
6.1 Europe Orphan Drug Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Orphan Drug Market, Revenues & Volume, By Biologics, 2021 - 2031 |
6.1.3 Europe Orphan Drug Market, Revenues & Volume, By Small Molecules, 2021 - 2031 |
6.1.4 Europe Orphan Drug Market, Revenues & Volume, By Gene Therapy, 2021 - 2031 |
6.1.5 Europe Orphan Drug Market, Revenues & Volume, By Cell Therapy, 2020 - 2028 |
6.1.6 Europe Orphan Drug Market, Revenues & Volume, By Others, 2020 - 2028 |
6.2 Europe Orphan Drug Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Orphan Drug Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Europe Orphan Drug Market, Revenues & Volume, By Genetic Disorders, 2021 - 2031 |
6.2.4 Europe Orphan Drug Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.2.5 Europe Orphan Drug Market, Revenues & Volume, By Autoimmune Disorders, 2021 - 2031 |
6.2.6 Europe Orphan Drug Market, Revenues & Volume, By Others, 2020 - 2028 |
6.3 Europe Orphan Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Orphan Drug Market, Revenues & Volume, By Prescription Drugs, 2021 - 2031 |
6.3.3 Europe Orphan Drug Market, Revenues & Volume, By Over-the-Counter, 2021 - 2031 |
6.3.4 Europe Orphan Drug Market, Revenues & Volume, By Specialty Drugs, 2021 - 2031 |
6.3.5 Europe Orphan Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3.6 Europe Orphan Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Europe Orphan Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Orphan Drug Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.4.3 Europe Orphan Drug Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.4.4 Europe Orphan Drug Market, Revenues & Volume, By Online Pharmacies, 2020 - 2028 |
6.4.5 Europe Orphan Drug Market, Revenues & Volume, By Specialty Clinics, 2020 - 2028 |
6.4.6 Europe Orphan Drug Market, Revenues & Volume, By Others, 2020 - 2028 |
7 Europe Orphan Drug Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Orphan Drug Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Orphan Drug Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Germany Orphan Drug Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 France Orphan Drug Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Poland Orphan Drug Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Spain Orphan Drug Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Rest of Europe Orphan Drug Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Europe Orphan Drug Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
7.3.1 United Kingdom (UK) Orphan Drug Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.3.2 Germany Orphan Drug Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.3.3 France Orphan Drug Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.3.4 Poland Orphan Drug Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.3.5 Spain Orphan Drug Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.3.6 Rest of Europe Orphan Drug Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.4 Europe Orphan Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.1 United Kingdom (UK) Orphan Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.2 Germany Orphan Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.3 France Orphan Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.4 Poland Orphan Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.5 Spain Orphan Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.4.6 Rest of Europe Orphan Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.5 Europe Orphan Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.1 United Kingdom (UK) Orphan Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.2 Germany Orphan Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.3 France Orphan Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.4 Poland Orphan Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.5 Spain Orphan Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.6 Rest of Europe Orphan Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Europe Orphan Drug Market Key Performance Indicators |
9 Europe Orphan Drug Market - Export/Import By Countries Assessment |
10 Europe Orphan Drug Market - Opportunity Assessment |
10.1 Europe Orphan Drug Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Orphan Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Europe Orphan Drug Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10.4 Europe Orphan Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.5 Europe Orphan Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 Europe Orphan Drug Market - Competitive Landscape |
11.1 Europe Orphan Drug Market Revenue Share, By Companies, 2022 |
11.2 Europe Orphan Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here